- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hypera SA ADR (HYPMY)
Hypera SA ADR stock price live, this page displays OTC HYPMY stock exchange data. View the HYPMY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hypera SA ADR real time stock price chart below.
What Is the Hypera SA ADR Stock Price Today?
The Hypera SA ADR stock price today is 4.15.
What Is the Stock Symbol for Hypera SA ADR?
The stock symbol for Hypera SA ADR is ""HYPMY.""
What Stock Exchange Does Hypera SA ADR Trade On?
Hypera SA ADR is listed and trades on the OTC Markets stock exchange.
Is Hypera SA ADR a Good Stock to Buy?
Determining whether Hypera SA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPMY quote. (ISIN: US44914U1060)
What Is the Hypera SA ADR Stock Price Today?
The Hypera SA ADR stock price today is 4.15.
What Is the Stock Symbol for Hypera SA ADR?
The stock symbol for Hypera SA ADR is ""HYPMY.""
What Stock Exchange Does Hypera SA ADR Trade On?
Hypera SA ADR is listed and trades on the OTC Markets stock exchange.
Is Hypera SA ADR a Good Stock to Buy?
Determining whether Hypera SA ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPMY quote. (ISIN: US44914U1060)
4.15
-0.17(-3.94%)
Closed·
Fair Value
An estimate of a Hypera ON ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.15
4.27
52 wk Range
2.64
5.36
HYPMY Scorecard
Full Analysis
High shareholder yield
HYPMY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Hypera ON ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.154.27
52 wk Range
2.645.36
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
HYPMY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Hypera ON ADR's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- HYPERMARCAS ON NM receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hypera SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hypera SA receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Hypera SA ADR Company Profile
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.
Compare HYPMY to Peers and Sector
Metrics to compare | HYPMY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHYPMYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.4x | 12.6x | −0.6x | |
PEG Ratio | −0.35 | 0.31 | 0.00 | |
Price/Book | 1.2x | 1.3x | 2.6x | |
Price / LTM Sales | 2.2x | 2.0x | 3.4x | |
Upside (Analyst Target) | - | 13.3% | 38.1% | |
Fair Value Upside | Unlock | 7.0% | 4.7% | Unlock |
Earnings
Latest Release
Aug 06, 2025
EPS / Forecast
0.68 / --
Revenue / Forecast
2.15B / --
People Also Watch
FAQ
What Stock Exchange Does Hypera ON ADR Trade On?
Hypera ON ADR is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Hypera ON ADR?
The stock symbol for Hypera ON ADR is "HYPMY."
What Is the Hypera ON ADR Market Cap?
As of today, Hypera ON ADR market cap is 2.71B.
What Is Hypera ON ADR's Earnings Per Share (TTM)?
The Hypera ON ADR EPS (TTM) is 1.17.
From a Technical Analysis Perspective, Is HYPMY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hypera ON ADR Stock Split?
Hypera ON ADR has split 0 times.
How Many Employees Does Hypera ON ADR Have?
Hypera ON ADR has 10481 employees.
What is the current trading status of Hypera ON ADR (HYPMY)?
As of 13 Sept 2025, Hypera ON ADR (HYPMY) is trading at a price of 4.15, with a previous close of 4.32. The stock has fluctuated within a day range of 4.15 to 4.27, while its 52-week range spans from 2.64 to 5.36.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.